The high concentrations of GH and insulin-like growth factor-1 (IGF-1) in the serum of patients with this rare endocrine disease affect their physiology and metabolism and cause a series of symptoms (2) that seriously affect their health and quality of life (3, 4). The gene discussed is IGF1; the disease is endocrine system disorder.